Characterization of the Gametocytocidal and Putative Transmission-Blocking Activity of Chlorotonil A Against Plasmodium falciparum
Thomas Martin Schäfer, Lais Pessanha de Carvalho, Linn Kruse, Arne Sommer, Omotayo Anick Jacquelina Bara, Barclaye Ngossanga, Maminirina Fidélis Ambinintsoa, Chiara Andolina, Peter F. Billingsley, Andreas M. Kany, Jennifer Herrmann, Rolf Müller, Ayola Akim Adegnika, Peter G. Kremsner, Steffen Borrmann, Jana HeldBackground: Chlorotonil A, a keto-macrolide produced by the myxobacterium Sorangium cellulosum, has potent antibiotic and antimalarial activities. Notably, chlorotonil A is active against both asexual and sexual blood-stage malaria parasites, making it a promising candidate for the development of an antimalarial treatment that also reduces parasite transmission to mosquitoes. Objectives: Here, we characterize the gametocytocidal and transmission-reducing activity of chlorotonil A. Methods and results: Using direct membrane feeding assays with Plasmodium falciparum isolates from a malaria-endemic area in Gabon, we show that chlorotonil A reduces oocyst infection prevalence and intensity in Anopheles gambiae (Kisumu) mosquitoes. Furthermore, we demonstrate that chlorotonil A is a particularly fast-acting gametocytocidal compound in vitro. Fluorescence and transmission electron microscopy revealed that chlorotonil A impairs membrane integrity and induces intracellular vacuolization after 6 h of drug exposure, with accumulation of reactive oxygen species (ROS) and intracellular acidification after 24 h. Conclusions: Our findings show that chlorotonil A has the potential for development as a dual-active antimalarial.